2022
DOI: 10.1002/adma.202200789
|View full text |Cite|
|
Sign up to set email alerts
|

A Biomaterial‐Based Hedging Immune Strategy for Scarless Tendon Healing

Abstract: Figure 4. Effects of Him-MFM on inflammation damaging and apoptotic stress and mobilized tenocyte functional proliferation. a) Immunohistochemical staining and evaluation of IL-1β and TNF-α expression in peritendinous adhesion area for 5 and 10 days. Scale bars: 5 µm. b) The positive area percent of IL-1β and TNF-α for 5 and 10 days (n = 6). c) Immunofluorescence staining for CD68 + macrophages, Ly6G + neutrophils, and DAPI. Scale bars: 5 µm. d) The number of macrophages and neutrophils in LPF at series time p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 58 publications
0
12
0
Order By: Relevance
“…Fascial flap transposition, tendon transposition, or tendon graft may be required for a defect of the same length in human patients to bridge the defect at the broken end of the Achilles tendon. In this experiment, our hypothesis was confirmed by the immunofluorescence staining results, i.e., the Wnt3a-modified tendon-repair scaffolds promoted the forward shift of the total macrophage counting curve during tendon regeneration in rats, and the number of macrophages in the Wnt3a group peaked at approximately 2 weeks and was equivalent to that in the control group at 4 weeks. The similar forward shift of the curve may indicate a better repair effect. , In terms of the macrophage subtypes, the proportion of M2 macrophages in the Wnt3a group was significantly higher than that in the control group during the repair process. Also, the proportion of M2 macrophages was significantly higher in the regenerated bridging portion of the regenerated tissue than in the distal part, which may suggest a phenomenon that M2 macrophages determine the subsequent tissue regeneration.…”
Section: Discussionmentioning
confidence: 84%
See 3 more Smart Citations
“…Fascial flap transposition, tendon transposition, or tendon graft may be required for a defect of the same length in human patients to bridge the defect at the broken end of the Achilles tendon. In this experiment, our hypothesis was confirmed by the immunofluorescence staining results, i.e., the Wnt3a-modified tendon-repair scaffolds promoted the forward shift of the total macrophage counting curve during tendon regeneration in rats, and the number of macrophages in the Wnt3a group peaked at approximately 2 weeks and was equivalent to that in the control group at 4 weeks. The similar forward shift of the curve may indicate a better repair effect. , In terms of the macrophage subtypes, the proportion of M2 macrophages in the Wnt3a group was significantly higher than that in the control group during the repair process. Also, the proportion of M2 macrophages was significantly higher in the regenerated bridging portion of the regenerated tissue than in the distal part, which may suggest a phenomenon that M2 macrophages determine the subsequent tissue regeneration.…”
Section: Discussionmentioning
confidence: 84%
“…61 A hedging immune strategy based microfibrous membrane (Him-MFM) has also shown promising results in scarless tendon healing. 11 However, additional basic research will be necessary to understand the optimal temporal and spatial presentation of macrophage involvement in tissue healing, and this will allow researchers to design better and more targeted biomaterials. In addition, the motor function of rats was also quantitatively evaluated.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In clinical practice, the massive tendon defect can not be repaired by simply end-to-end suturing or using autografts due to the length or resource restriction, which commonly need the extra allografts or some biomaterials to handle this challenge. Currently, most of the commercially biological products are mammal-derived collagen products, like acellular small intestine submucosa (SIS), dermis, and pericardium [ 56 ]. However, just as we mentioned in introduction section, these mammal-derived decellularized ECMs have limitations such as limited donor sources, the potential risk of zoonotic diseases, and ethical and religious issues [ 20 ].…”
Section: Discussionmentioning
confidence: 99%